Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01996111 · ClinicalTrials.gov registry record · NA
Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis
A NA study, sponsored by MiMedx Group.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01996111: Clinical Trial NA study, sponsored by MiMedx Group.
NCT01996111 is a NA study that was terminated before completion, run by MiMedx Group. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01996111, a NA study, was terminated before completion, sponsored by MiMedx Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is a prospective, controlled, randomized, blinded and comparative, single-center clinical trial comparing the improvement of patients with recalcitrant plantar fasciitis symptoms that have received standard of care versus treatment with differing amounts of injectable dehydrated human amnion/chorion membrane micrografts(dHACM).
Primary Outcome
The primary objective of this study is to compare the efficacy of the different treatment amounts in reduction of inflammation as measured by AOFAS Hindfoot scores.
Interventions
- PROCEDURE Injection of 1.0 cc of 0.9% Saline
- PROCEDURE Injection of 1.0 cc of 10 mg/ml micrograft dHACM suspension
- PROCEDURE Injection of 1.0 cc of 20 mg/ml micrograft dHACM suspension
- PROCEDURE Injection of 1.0 cc of 40 mg/ml micrograft dHACM suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-04 |
| Phase | NA |
Why NCT01996111 stopped before completion
NCT01996111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Injection of 1.0 cc of 0.9% Saline is the first listed.
NCT01996111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01996111 about?
NCT01996111 is a clinical study titled "Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis". This is a prospective, controlled, randomized, blinded and comparative, single-center clinical trial comparing the improvement of patients with recalcitrant plantar fasciitis symptoms that have received standard of care versus treatment with differing amounts of injectable dehydrated human amnion/ch...
What is the current status of trial NCT01996111?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2013-09. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01996111?
The interventions under investigation include: Injection of 1.0 cc of 0.9% Saline (PROCEDURE), Injection of 1.0 cc of 10 mg/ml micrograft dHACM suspension (PROCEDURE), Injection of 1.0 cc of 20 mg/ml micrograft dHACM suspension (PROCEDURE), Injection of 1.0 cc of 40 mg/ml micrograft dHACM suspension (PROCEDURE).
Who is sponsoring clinical trial NCT01996111?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01996111's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia